Evidence map›Paper›PMID 9736613›Full record

ArticleThe EMBO journal1998

Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection.

T Schmidt, H Karsunky, B Rödel, B Zevnik, H P Elsässer, T Möröy

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The role of Pim kinase in immunomodulation.American journal of cancer research · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Transcription factors and target genes of pre-TCR signaling.Cellular and molecular life sciences : CMLS · 2015
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Eliciting the T cell fate with Notch.Seminars in immunology · 2010
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

T SchmidtInstitut für Zellbiologie (Tumorforschung), IFZ, Universitätsklinikum Essen, Virchowstrasse 173, D-45122 Essen, Germany.
H Karsunky
B Rödel
B Zevnik
H P Elsässer
T Möröy
Institut für Medizinische Informatik, Biometrie und Epidemiologie · DEEssen University Hospital · DEPhilipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After rearrangement of the T-cell receptor (TCR) beta-locus, early CD4(-)/CD8(-) double negative (DN) thymic T-cells undergo a process termed 'beta-selection' that allows the preferential expansion of cells with a functional TCR beta-chain. This process leads to the formation of a rapidly cycling subset of DN cells that subsequently develop into CD4(+)/CD8(+) double positive (DP) cells. Using transgenic mice that constitutively express the zinc finger protein Gfi-1 and the serine/threonine kinase Pim-1, we found that the levels of both proteins are important for the correct development of DP cells from DN precursors at the stage where 'beta-selection' occurs. Analysis of the CD25(+)/CD44(-,lo) DN subpopulation from these animals revealed that Gfi-1 inhibits and Pim-1 promotes the development of larger beta-selected cycling cells ('L subset') from smaller resting cells ('E subset') within this subpopulation. We conclude from our data that both proteins, Pim-1 and Gfi-1, participate in the regulation of beta-selection-associated pre-T-cell differentiation in opposite directions and that the ratio of both proteins is important for pre-T-cells to pass the 'E' to 'L' transition correctly during beta-selection.

Indexed as

Cell Cycle ProteinsProtein Serine-Threonine KinasesTranscription FactorsTumor Suppressor ProteinsAnimalsCD4 AntigensCD8 AntigensCell DifferentiationCrosses, GeneticCyclin-Dependent Kinase Inhibitor p27DNA-Binding ProteinsGene Rearrangement, T-LymphocyteGenes, bcl-2Hyaluronan ReceptorsLeukopoiesisMiceCD4 AntigensCD8 AntigensCdkn1b protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27DNA-Binding ProteinsGfi1 protein, mouseHyaluronan ReceptorsMicrotubule-Associated ProteinsPim1 protein, mouseProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-pim-1Receptors, Antigen, T-Cell, alpha-betaReceptors, Interleukin-2Transcription FactorsTumor Suppressor Proteins

Identifiers

PMID9736613
PMCPMC1170861
OpenAlexW2071329887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.